- Home
- PTIX vs APDN Comparison
PTIX vs APDN Comparison
Compare PTIX & APDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTIX
- APDN
- Stock Information
- Founded
- PTIX 1994
- APDN 1983
- Country
- PTIX United States
- APDN United States
- Employees
- PTIX N/A
- APDN N/A
- Industry
- PTIX Biotechnology: Pharmaceutical Preparations
- APDN Other Consumer Services
- Sector
- PTIX Health Care
- APDN Consumer Discretionary
- Exchange
- PTIX Nasdaq
- APDN Nasdaq
- Market Cap
- PTIX 2.0M
- APDN 2.0M
- IPO Year
- PTIX 2016
- APDN N/A
- Fundamental
- Price
- PTIX $0.42
- APDN $1.65
- Analyst Decision
- PTIX
- APDN Strong Buy
- Analyst Count
- PTIX 0
- APDN 1
- Target Price
- PTIX N/A
- APDN $75.00
- AVG Volume (30 Days)
- PTIX 324.0K
- APDN 2.6M
- Earning Date
- PTIX 05-14-2025
- APDN 05-09-2025
- Dividend Yield
- PTIX N/A
- APDN N/A
- EPS Growth
- PTIX N/A
- APDN N/A
- EPS
- PTIX N/A
- APDN N/A
- Revenue
- PTIX N/A
- APDN $3,736,873.00
- Revenue This Year
- PTIX N/A
- APDN $57.08
- Revenue Next Year
- PTIX N/A
- APDN $40.00
- P/E Ratio
- PTIX N/A
- APDN N/A
- Revenue Growth
- PTIX N/A
- APDN N/A
- 52 Week Low
- PTIX $0.18
- APDN $1.45
- 52 Week High
- PTIX $1.87
- APDN $450.00
- Technical
- Relative Strength Index (RSI)
- PTIX 67.76
- APDN 21.70
- Support Level
- PTIX $0.18
- APDN $1.45
- Resistance Level
- PTIX $0.28
- APDN $2.06
- Average True Range (ATR)
- PTIX 0.04
- APDN 0.28
- MACD
- PTIX 0.01
- APDN 0.12
- Stochastic Oscillator
- PTIX 62.39
- APDN 13.81
About PTIX Protagenic Therapeutics Inc.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.
About APDN Applied DNA Sciences Inc.
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.